Fidelio T, Mandolfo S, Calitri V, Licata C, Iacono G, Sancipriano G P, Ragni R, Pecchio F
U.S.S.L. n. 27, Ciriè (Torino), Servizio di Nefrologia e Dialisi.
Minerva Urol Nefrol. 1990 Jan-Mar;42(1):35-8.
The Authors have evaluated the possibilities of use of the PFD in the regular dialysis treatment. At first they have studied in 8 patients the advantages offered by this technique in terms of depuration of small molecules and of tolerance in comparison with HD and HDF. Subsequently, they have compared the performances obtained in HF in a second group of 7 patients with the results observed in PFD executed by using 2 dialyzers on line and, in a second phase, in parallel, extending the comparison parameters to a higher molecular weight solute such as the beta 2-M. The results obtained indicate the PFD as a technique which can offer (compared to HD) a better tolerance and higher depurative performances, which on their turn can eventually allow a reduction of the length of the treatment. Moreover the possibility of executing the PFD with 2 polysulfone dialyzers on line and in parallel, increasing the UF to 13.5 and 15 L, renders this technique competitive with the HF also for its capacity of removing the beta 2-M.
作者评估了在常规透析治疗中使用在线配对滤过透析(PFD)的可能性。首先,他们在8名患者中研究了该技术在小分子清除及与血液透析(HD)和高通量透析(HDF)相比的耐受性方面所具有的优势。随后,他们将第二组7名患者进行血液滤过(HF)所获得的结果,与使用2个在线透析器进行在线配对滤过透析所观察到的结果进行比较,并且在第二阶段进行平行比较,将比较参数扩展到更高分子量的溶质,如β2-微球蛋白(β2-M)。所获得的结果表明,在线配对滤过透析作为一种技术(与血液透析相比)可以提供更好的耐受性和更高的清除性能,进而最终有可能缩短治疗时间。此外,使用2个聚砜在线透析器并行进行在线配对滤过透析,将超滤量提高到13.5和15L,使得该技术在清除β2-微球蛋白的能力方面也与血液滤过具有竞争力。